BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

817 related articles for article (PubMed ID: 11148007)

  • 1. Drug targets and mechanisms of resistance in the anaerobic protozoa.
    Upcroft P; Upcroft JA
    Clin Microbiol Rev; 2001 Jan; 14(1):150-64. PubMed ID: 11148007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites.
    Cedillo-Rivera R; Chávez B; González-Robles A; Tapia A; Yépez-Mulia L
    J Eukaryot Microbiol; 2002; 49(3):201-8. PubMed ID: 12120985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug susceptibility testing of anaerobic protozoa.
    Upcroft JA; Upcroft P
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1810-4. PubMed ID: 11353630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keto-acid oxidoreductases in the anaerobic protozoa.
    Upcroft JA; Upcroft P
    J Eukaryot Microbiol; 1999; 46(4):447-9. PubMed ID: 10461388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis.
    Adagu IS; Nolder D; Warhurst DC; Rossignol JF
    J Antimicrob Chemother; 2002 Jan; 49(1):103-11. PubMed ID: 11751773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial.
    Leitsch D
    Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):321-327. PubMed ID: 28910741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp.
    Upcroft JA; Campbell RW; Benakli K; Upcroft P; Vanelle P
    Antimicrob Agents Chemother; 1999 Jan; 43(1):73-6. PubMed ID: 9869568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis.
    Jarrad AM; Debnath A; Miyamoto Y; Hansford KA; Pelingon R; Butler MS; Bains T; Karoli T; Blaskovich MA; Eckmann L; Cooper MA
    Eur J Med Chem; 2016 Sep; 120():353-62. PubMed ID: 27236016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current and future perspectives on the chemotherapy of the parasitic protozoa Trichomonas vaginalis and Entamoeba histolytica.
    Moya IA; Su Z; Honek JF
    Future Med Chem; 2009 Jul; 1(4):619-43. PubMed ID: 21426030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly Potent 1
    Kumar S; Bains T; Won Kim AS; Tam C; Kim J; Cheng LW; Land KM; Debnath A; Kumar V
    Front Cell Infect Microbiol; 2018; 8():380. PubMed ID: 30425970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.
    Dunne RL; Dunn LA; Upcroft P; O'Donoghue PJ; Upcroft JA
    Cell Res; 2003 Aug; 13(4):239-49. PubMed ID: 12974614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
    Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
    Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trichomonads, hydrogenosomes and drug resistance.
    Kulda J
    Int J Parasitol; 1999 Feb; 29(2):199-212. PubMed ID: 10221623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of iron on metronidazole activity against Trichomonas vaginalis in vitro.
    Elwakil HS; Tawfik RA; Alam-Eldin YH; Nassar DA
    Exp Parasitol; 2017 Nov; 182():34-36. PubMed ID: 28935536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trichomonas vaginalis: metronidazole and other nitroimidazole drugs are reduced by the flavin enzyme thioredoxin reductase and disrupt the cellular redox system. Implications for nitroimidazole toxicity and resistance.
    Leitsch D; Kolarich D; Binder M; Stadlmann J; Altmann F; Duchêne M
    Mol Microbiol; 2009 Apr; 72(2):518-36. PubMed ID: 19415801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis.
    Upcroft JA; Dunn LA; Wright JM; Benakli K; Upcroft P; Vanelle P
    Antimicrob Agents Chemother; 2006 Jan; 50(1):344-7. PubMed ID: 16377707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High rates of double-stranded RNA viruses and Mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil.
    da Luz Becker D; dos Santos O; Frasson AP; de Vargas Rigo G; Macedo AJ; Tasca T
    Infect Genet Evol; 2015 Aug; 34():181-7. PubMed ID: 26160539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of methylgerambullin from Glycosmis species (Rutaceae) against Entamoeba histolytica and Giardia duodenalis in vitro.
    Drinić M; Raninger A; Zraunig A; Astelbauer F; Leitsch D; Obwaller A; Walochnik J; Greger H; Duchene M
    Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():109-117. PubMed ID: 31472356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Indicators of Drug Resistance in the Highly Repetitive Genome of Trichomonas vaginalis.
    Bradic M; Warring SD; Tooley GE; Scheid P; Secor WE; Land KM; Huang PJ; Chen TW; Lee CC; Tang P; Sullivan SA; Carlton JM
    Genome Biol Evol; 2017 Jun; 9(6):1658-1672. PubMed ID: 28633446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic review of the literature on mechanisms of 5-nitroimidazole resistance in
    Graves KJ; Novak J; Secor WE; Kissinger PJ; Schwebke JR; Muzny CA
    Parasitology; 2020 Nov; 147(13):1383-1391. PubMed ID: 32729451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.